VDR rs2228570: Understanding the FokI Variant
The rs2228570 variant is a well-studied genetic change located in the VDR gene, which provides instructions for the vitamin D receptor. This variant is frequently investigated for its potential influence on how the body processes vitamin D and its possible associations with bone mineral density and other health outcomes.
What each genotype means
FokI C allele homozygote
This genotype is sometimes referred to as the 'F' allele in older literature, which corresponds to a specific translation start site in the vitamin D receptor. Some research suggests this genotype may be associated with different risks for metabolic conditions like type 2 diabetes or autoimmune disorders in certain populations, though findings are often inconsistent across different ethnic groups. Because these associations are complex and vary by ancestry, this result should not be used to predict personal health outcomes.
This is a common genotype found globally, though its prevalence varies significantly depending on ancestral background.
FokI heterozygote
Carrying one copy of each allele means you possess both versions of the vitamin D receptor initiation site described in research. Studies investigating this variant often look at how it influences vitamin D sensitivity or disease susceptibility, but results are frequently mixed and highly dependent on the specific population studied. There is no consensus on a direct clinical impact for this genotype, and it is considered a normal variation in the human genome.
This is a very common genotype observed across most major population groups.
FokI T allele homozygote
This genotype is sometimes referred to as the 'f' allele in older scientific literature. While some studies have explored whether this variant influences vitamin D receptor function or susceptibility to various health conditions, the evidence remains inconclusive and often contradictory across different studies. It is considered a common genetic variation, and its presence does not provide a clear indication of health risk or specific medical status.
This genotype is found at varying frequencies worldwide and is considered a standard variation in the human population.
What is rs2228570?
The rs2228570 variant, commonly referred to as the FokI polymorphism, is a single nucleotide polymorphism (SNP) located within the VDR gene. This specific variant is located at the translation initiation site of the gene. Because of its position, the presence of different alleles can lead to the production of vitamin D receptor proteins that vary slightly in length and potentially in their functional activity. Specifically, the variant can result in a protein that is three amino acids shorter than the alternative form. Because this change occurs at the very beginning of the protein-coding sequence, researchers have long hypothesized that it could alter the efficiency or regulation of the receptor, which is a critical component in the body's ability to respond to vitamin D.
The Role of the VDR Gene
The VDR gene encodes the vitamin D receptor, a protein that acts as a transcription factor. When vitamin D binds to this receptor, the complex moves into the cell nucleus and binds to specific DNA sequences, effectively turning genes on or off. This process is essential for maintaining calcium homeostasis, which is vital for bone mineralization and overall skeletal health. Beyond bone health, the vitamin D receptor is involved in a wide array of physiological processes, including immune system regulation, cell proliferation, and the metabolism of various minerals. Because vitamin D signaling is so widespread throughout the body, variations in the VDR gene are frequently studied to see if they contribute to differences in how individuals respond to vitamin D levels or their susceptibility to various health conditions.
Research and Evidence
Research into rs2228570 has produced mixed and often contradictory results. Early studies suggested that the variant might influence peak bone mineral density, particularly at the femoral neck, though these findings have not been consistently replicated across all populations. Other researchers have investigated the variant's potential link to conditions such as type 2 diabetes, intervertebral disc degeneration, and certain cancers. However, many of these studies have found little to no significant association, or the evidence remains limited and inconclusive. It is important to note that genetic associations are often complex and can be influenced by environmental factors, such as dietary vitamin D intake, sun exposure, and overall lifestyle. Currently, the evidence linking this specific SNP to major clinical outcomes is considered limited, and it is not used as a diagnostic tool in clinical practice.
What You Can and Cannot Do
It is important to understand that having a particular genotype for rs2228570 does not provide a definitive prediction of your health. Because the scientific evidence for this variant is limited and often conflicting, it cannot be used to diagnose conditions or predict specific health outcomes. Genetic information should never be used to make independent medical decisions, such as altering your diet or changing medication dosages. If you are concerned about your vitamin D levels or bone health, the most effective approach is to consult with a healthcare professional. They can order appropriate blood tests to measure your actual vitamin D levels and provide personalized guidance based on your medical history, lifestyle, and clinical needs. Always discuss any questions regarding genetic testing or health supplements with your doctor or a qualified pharmacist.
How common is this variant?
The rs2228570 variant is common globally, with a minor allele frequency typically ranging between 0.35 and 0.40 across diverse populations.
Frequently asked questions
Does rs2228570 mean I have a vitamin D deficiency?
No. This variant relates to the structure of the vitamin D receptor, not your current blood levels of vitamin D. Vitamin D deficiency is primarily determined by factors like sun exposure, diet, and supplementation, which can be measured by a blood test from your doctor.
Should I take more vitamin D if I have the 'risk' genotype?
You should not change your supplement routine based on this genetic variant. Always consult your healthcare provider to determine if you need vitamin D supplementation based on your blood work and clinical health status.
Is rs2228570 a diagnostic test for bone health?
No, this variant is not used for clinical diagnosis. Bone health is a complex trait influenced by many genes and environmental factors, and this SNP does not provide enough information to predict your bone density or fracture risk.
Why do studies show different results for this variant?
Genetic studies often vary due to differences in study design, the size of the participant groups, and the ancestry of the populations studied. Additionally, environmental factors like diet and lifestyle can mask or influence the effects of a single genetic variant.
Sources & further reading
Educational information only, last refreshed 10/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2228570?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in VDR
Variant in the promoter region (Cdx2 site) of the vitamin D receptor gene associated with altered intestinal calcium absorption and bone mineral density.
This variant in the Vitamin D receptor gene is associated with susceptibility to Type 1 Diabetes and autoimmune thyroid disease.
Promoter polymorphism (Cdx2) in the VDR gene associated with bone mineral density and vitamin D metabolism.
Common polymorphism (TaqI variant) in the vitamin D receptor affecting mRNA stability and bone mineral density.
Known as the TaqI polymorphism, this variant is located in the 3' UTR of the VDR gene and is associated with altered mRNA stability, influencing vitamin D signaling, cancer cachexia susceptibility, and gastric cancer risk.
Variant in the VDR promoter (Cdx-2 binding site) associated with bone mineral density and calcium absorption efficiency.